Apollo Health Ventures
Apollo Health Ventures is a transatlantic early-stage venture capital firm founded in 2017 with dual offices in Berlin and Boston (plus Luxembourg) that co-founds and backs biotechnology companies targeting age-related diseases and the biology of ageing. It combines a Venture Lab company-creation model with external early-stage dealflow, seeding roughly 15 longevity-focused biotech ventures across the US and Europe. Its EUR 157.5m Fund II closed in December 2021 and is backed by institutional LPs including KfW Capital.
Key facts
Recent exits
No exits recorded yet.
Coverage notes
2 funds tracked, 11 portfolio companies (11 active · 0 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Apollo Health Ventures has raised, with its portfolio companies. Hand-checked from public filings.
Apollo Health Ventures Fund IILife Sciences VC2021 · 5yr€158M8 active
Unrealized
8 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Auron Therapeutics | Biotech | United States | 2022 |
| Bloom Science | Biotech | United States | 2021 |
| Booster Therapeutics | Biotech | Germany | 2024 |
| Cleara Biotech | Biotech | Netherlands | 2022 |
| Focal Biosciences | Biotech | Switzerland | 2022 |
| HAYA Therapeutics | Biotech | Switzerland | 2021 |
| Ochre Bio | Biotech | United Kingdom | 2021 |
| Therini Bio | Biotech | United States | 2025 |
Apollo Health Ventures Fund IEvergreen2018 · 8yr3 active
Unrealized
3 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Aeovian Pharmaceuticals | Biotech | United States | 2019 |
| Refoxy Pharmaceuticals | Biotech | Germany | 2020 |
| Samsara Therapeutics | Biotech | United Kingdom | 2019 |
Saved GPs appear in your watchlist, one click from your workspace.
Similar firms
Other private equity firms tracked on GP Intel.
Germany·€20.0BGermany·€3.0BGermany·€2.8BGermany·€2.3BGermany·€1.9BGermany·€1.8BGermany·€1.8BGermany·€1.5BGermany·€1.5BGermany·€1.4BGermany·€1.4BGermany·€1.3B